Trials / Completed
CompletedNCT00447876
Study to Assess the Efficacy and Safety of Dysport® in the Treatment of Chronic Plantar Fasciitis
Double-blind, Placebo-controlled, Randomised, Multicentre Study on the Efficacy and Safety of a Single Injection of Botulinum Toxin A (200 Units Dysport®) in the Treatment of Chronic Plantar Fasciitis
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Ipsen · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will investigate the hypothesis that the analgesic effect of a single injection of Dysport (200 MU) induces a significant reduction of symptoms in chronic cases of plantar fasciitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Botulinum toxin type A | Botulinum type A toxin (Dysport®): 200 Units injected at the root of the plantar fascia |
| DRUG | Placebo | 0.9% sodium chloride: 2 ml injected at the root of the plantar fascia |
Timeline
- Start date
- 2005-07-01
- Primary completion
- 2009-01-01
- Completion
- 2009-04-01
- First posted
- 2007-03-15
- Last updated
- 2019-11-22
- Results posted
- 2017-06-23
Locations
6 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT00447876. Inclusion in this directory is not an endorsement.